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Synergistic effect of a-adducin and ACE genes causes blood hypertension and its cardiac complications is still under
pressure changes with body sodium and volume expansion. discussion. A series of observations has a consistent hy-
Background. The genetic dissection of a polygenic, multifac- pothesis that genetic mechanisms influence the relation-torial, quantitative disease such as arterial hypertension is ham-
ship between Na intake and blood pressure (BP): (1)pered by a large environmental variance and by genetic hetero-
Not all humans have an increased BP when their Nageneity.
Methods. To reduce the environmental variance, we mea- intake is increased, and their genetic background influ-
sured the pressor response to a saline load (PRSL) and the ences this BP response [1]. (2) Salt sensitivity could be
basal plasma renin activity (PRA) under very controlled condi-
observed only in some, but not in all, animals in a colonytions in 145 essential hypertensive patients, as they may have
of outbred, unrelated chimpanzees, the primate philo-the most direct clinical expression of the putative genetic alter-
ation in renal Na handling and blood pressure (BP) regulation genetically closest to humans [2]. (3) Some rat strains
caused by the a-adducin and angiotensin-converting enzyme develop genetic hypertension only if they ingest an ex-
(ACE) polymorphism. cess of Na in their diets [3].
Results. PRSL was smaller in patients homozygous for the
Although BP is influenced by many factors, pressurewild-type (Gly460) variant of a-adducin compared with that
natriuresis plays an especially important role because itof patients bearing at least one copy of the 460Trp variant (2.5 6
0.6 vs. 7.0 6 0.9 mm Hg, P 5 0.0001), whereas the ACE expresses the ability of the kidney to adjust Na excretion
genotype was not associated with differences in PRSL. Both for a given perfusion pressure. It is the major determi-
a-adducin and ACE affect PRA, with lower values correlated nant of the individual BP response to body Na changes.with the number of 460Trp or D alleles (P 5 0.019 and 0.017,
This key regulatory mechanism has to be reset in orderrespectively). Most important, a-adducin and ACE interact
epistatically in determining the PRSL, doubling the variance to produce permanent BP changes [4]. Understanding
explained when epistasis is taken into account (variance from its genetic control is of paramount importance in as-
7.7 to 15.5%). sessing the causes of primary hypertension [5]. Two inde-
Conclusion. These findings support the involvement of ACE
pendent considerations suggest that pressure natriuresisand a-adducin in PRSL and PRA control, which are of para-
is influenced by many genes: (1) Multiple systems aremount importance in setting the BP level and its response to
therapy. involved, such as the sympathetic, renin-angiotensin,
membrane transport, natriuretic factors systems, etc. (2)
Being philogenetically ancient, protective homeostatic
Primary or essential arterial hypertension, which af- functions and genetic redundancy are likely to occur
fects about 20% of the adult population of Western coun- [6]. The relationship between systemic arterial pressure,
tries, is a major risk factor for cardiac, renal, and cerebro- renal perfusion pressure, and Na excretion developed at
vascular diseases. In spite of more than 40 years of least 300- to 400-million years ago with teleosts [7]. To
research, the role of excessive Na intake in promoting complicate the matter further, it should also be kept in
mind that whenever an association is found between a
gene polymorphism and a phenotype, the possibility thatKey words: renin-angiotensin system, genetics, epistatic interaction,
hypertension, pressor response, angiotensin converting enzyme. another gene mapping in close proximity to the one
under study is the real causal gene cannot be excluded.Received for publication May 20, 1999
Such a phenomenon could thus complicate gene-mappingand in revised form August 26, 1999
Accepted for publication September 16, 1999 studies. The demonstration of synergistic or interactive
effects of two genes mapping on different chromosomes,Ó 2000 by the International Society of Nephrology
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both with a plausible role in causing the phenotype, METHODS
would not only strongly reinforce their involvement, but Patients
also may help us understand the complexity of the ge-
One hundred fifty-eight essential hypertensive pa-netic architecture of BP regulation [8].
tients were recruited from the “Outpatient Clinic forWe recently identified a polymorphism within the
Hypertension” of San Raffaele Hospital of Milano (It-
a-adducin gene, which is associated with hypertension in
aly). The following exclusion criteria were used: (1) his-Milan hypertensive strain (MHS) rats and in a subset of
tory of myocardial infarction, congestive heart failure,humans [9, 10]. This association has been confirmed in
stroke, creatinine clearance 5 80 mL/min, diabetes melli-other Caucasian [11] and Japanese populations [12, 13],
tus, liver disease; (2) severe hypertension requiring im-but not by other researchers [14, 15]. Adducin is a cy-
mediate treatment; (3) women on oral contraceptives;toskeleton protein with very high degree of homology
and (4) individuals who were known to abuse drugs or(94%) between rats and humans. The different a-adducin
alcohol. Inclusion criteria were: (1) a BP value greaterisoforms differentially affect the Na1,K1 pump activity
than 145/95 but lower than 180/120 mm Hg in at leaston the basolateral tubular membrane, which is the driv-
three consecutive visits at the outpatient clinic, and (2)ing force of overall tubular Na reabsorption [16]. This
a 24-hour ambulatory BP recording (Spacelabs 90207)may explain why the patients with “hypertensive”
with a mean daytime BP of greater than 140/90 mm(460Trp) a-adducin alleles are salt sensitive [10], have a
Hg, or (3) pre-existing antihypertensive treatment. Theless steep pressure natriuresis relationship [17], have an
exclusion criteria of the use of oral contraceptives ledincreased proximal tubular reabsorption [18], and have
to the recruitment of far fewer women than men. Fivea larger BP fall after diuretic treatment and lower plasma
patients were later excluded because of secondary hyper-renin activity (PRA) [10] when compared with patients
tension (discussed later in this article). A large numberhomozygous for the “wild-type” (Gly460) adducin allele.
of the patients studied had a recent diagnosis of hyper-From an evolutionary point of view, the function of
tension or had never been treated before, so they couldthe renin-angiotensin system (RAS) has been to regulate
undergo the loading protocol within two to three weeks,blood volume and Na homeostasis since the emergence
provided that their usual Na intake was around 150 mmolof amphibians, in which it is known that low nonpressor
Na per day, which is the average for the population livingdoses of angiotensin (Ang) increase tubular Na reab-
in the Milan area (checked by measuring 24-h urinarysorption without affecting the glomerular filtration rate
Na excretion). Otherwise, they were instructed to keep[19]. An increased Ang II level shifts to the right and
an average intake of 150 mmol Na/day for at least onereduces the steepness of the slope of the pressure-natri-
month before Na loading. Of the 40 patients who haduresis relationship, causing salt sensitivity, as shown with
already been taking antihypertensive treatment, somethe infusion of subpressor doses of Ang II in the dog
had spontaneously discontinued it months before for[20] and in transgenic (mRen-2)27 rats [21]. This mecha-
various reasons, and others agreed to discontinue it fornism is at least in part mediated by an Ang II-induced
at least four months. In general, the therapy withdrawalincrease of the activity of the Na1-H1 exchanger [22]
occurred during the summer because of the spontaneousand of the Na1,K1-pump [23]. Therefore, we postulated
BP reduction in this season, with consequent easier re-that a-adducin and the various proteins of the RAS could
moval of the therapy. We decided to perform such aninteract (or cooperate) in the pressor response to changes
unusually long period of therapy withdrawal to avoidin body Na. Among the possible candidate gene poly-
any residual carryover effect of the previous treatment.morphisms associated with the RAS, the angiotensin-
This may be particularly important for patients takingconverting enzyme (ACE) insertion/deletion (I/D) poly-
diuretics or ACE inhibitors that may induce hypertrophymorphism was chosen because the D allele is associated
of the cells of the juxtaglomerular apparatus, which maywith higher plasma and tissue ACE levels [24–27].
take a long time to normalize. During the period ofTherefore, the aim of our study was twofold: (1) to
therapy withdrawal, the BP values were recorded at leasttest whether the ACE gene I/D polymorphism affects
every two weeks, and pharmacological treatment wasthe relationship between BP and acute changes of body
resumed if the patient’s diastolic BP exceeded 105 mmNa content; and (2) to evaluate a possible synergistic
Hg. This led to the exclusion of five previously enrolledeffect or epistatic interaction between a-adducin poly-
patients. Three patients did not show any BP increasemorphism and ACE polymorphism on the pressure natri-
after treatment was discontinued and are presently stilluresis relationship. The study was carried out in 145
in pharmacological washout; they were then excludeduntreated, essential hypertensive patients, with a constant
from the study. Also, the hypertensive patients in phar-Na intake of around 150 mEq a day for a month prior
macological washout were advised to keep a constantto the study in order to minimize all possible sources of
Na intake of approximately 150 mEq a day for at leastvariation that could hamper the detection of an influence
of polymorphisms on the phenotypes under investigation. one month before the study. All participants gave their
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informed consent to the study. The present study is part riophage T4-polynucleotide kinase and used for hybrid-
ization.of a larger study on the genetic mechanisms of hyperten-
sion that has been approved by the Ethical Committee The ID ACE gene polymorphism was detected, as
described in Lindpainter et al [28]. Genomic DNA (100of San Raffaele Hospital.
ng) was amplified in a total volume of 30 mL containing
Acute salt-loading test 18 pmol of each primer, 670 mmol/L Tris-HCl, pH 8.8,
160 mmol/L (NH4)2 SO4, 0.5% NP40, 50 mmol/L b mer-Patients were admitted to the hospital on Saturday
morning, and they kept the same 150 mmol Na diet while captoethanol, 1.3 mmol/L MgCl2, 200 mmol/L of each
deoxynucleotide triphosphate, and 1 U Taq polymerase.in the hospital. They underwent clinical examination,
routine biochemistry, and tests for the exclusion of sec- The sense oligonucleotide primer was 59 GCCCTGCA
GGTGTCTGCAGCATGT 39, and the antisense primerondary forms of hypertension between Saturday and
Monday. The tests for the exclusion of secondary hyper- was 59 GGATGGCTCTCCCCGCCTTGTCTC 39. Am-
plification was carried out under the following condi-tension comprised renal function, plasma and urinary K,
urinalysis, plasma renin activity (PRA), renal and supra- tions: 35 cycles of 30 seconds at 948, 45 seconds at 568,
and 2 minutes at 728. As the D allele in heterozygousrenal gland echography with color Doppler echography
of the renal vasculature and, in case of any doubt, nuclear individuals was amplified preferentially, a second PCR
step followed it for all samples genotyped as D/D in themagnetic resonance (MR) angiography of the renal vas-
culature, MR of the suprarenal glands, and MR urogra- first step, with primers that amplified a specific insertion
sequence. PCR conditions were as before except for anphy. Exclusion of secondary forms of hypertension was
done during the hospital stay in order to have the patient annealing temperature of 678 and the following primers:
sense oligonucleotide primer 59 TGGGACCACAGCGaccustomed to different clinical maneuvers and to mini-
mize possible sources of environmental variation on the CCCGCCACTAC 39, antisense primer 59 TCGCCAG
CCCTCCCATGCCCATAA 39.different patients. Secondary forms of hypertension were
detected in five patients who were excluded from the
Statistical analysisstudy. PRA was measured on Saturday morning. Na
loading was performed on Wednesday morning and con- Basic statistics. Differences between groups were ana-
lyzed with Student’s t-test and one- or two-way analy-sisted in the intravenous infusion of 2 L of saline (310
mmol NaCl) in two hours. BP was measured with a sis of variance (ANOVA) or analysis of covariance
(ANCOVA, as specified in the Results section). To cal-standardized procedure three times at five-minute inter-
vals, before the beginning of loading, and three times, culate the deviation from the Hardy–Weinberg equilib-
rium and sex ratios with x2, the SPSS (version 4.05)five minutes before, immediately after, and five minutes
after the end of loading. BP values used in the analysis statistical software on an Apple Macintosh G3 personal
computer was used. The significance level was set to P ,were the averages of the three readings. Urinary Na
excretion during the loading was also measured. 0.05. Data are expressed as mean values 6 SEM.
Test for interaction. Two-locus model fitting and hy-
Genotyping pothesis testing was conducted via the least-squares re-
gression analysis [29] with SAS statistical software on aThe G460W polymorphism was investigated by poly-
merase chain reaction (PCR) amplification of genomic workstation. The following simple linear model was fit
to the data:DNA followed by allele specific oligonucleotide hybrid-
ization as described by Cusi et al [10]. Genomic DNA
yi 5 b0 1 o
C
j51
bcjcj,i 1 bACEgACE,i 1 bG460gG460,i 1 bIntgInt,i 1 ei(100 ng) was subjected to amplification using the follow-
ing primers: forward 59 GACAAGATGGCTGAACTC
where y is a phenotype of interest gathered from individ-TGG 39 and reverse 59 AGTCTTCGACTTGGGACT
ual i, b0 is an intercept term, bcj is a coefficient measuringGC 39 in a total volume of 30 mL containing 10 mmol/L
the effect of the jth [age, gender, body mass index (BMI),Tris-HCl (pH 8.8), 50 mmol/L KCl, 1.5 mmol/L MgCl2,
mean BP and basal urinary Na excretion] of the pheno-0.1% Triton X-100, 15 pmol of each primer, 200 mmol/L
type (C is the number of covariates included in theof each deoxynucleotide triphosphate, and 1 U Taq poly-
model). cj,i is a covariate measure on the jth covariatemerase. Amplification was carried out under the follow-
(dichotomous covariates were transformed into dummying conditions: 1 cycle of 4 minutes at 958, 30 seconds at
variables; for example, gender was assigned as 0 5 fe-578, and 30 seconds at 728, followed by 30 seconds at 958,
male, 1 5 male); bACE and bG460 are regression coefficients20 seconds at 578, and 30 seconds at 728. Allele-spec-
measuring the effect of the ACE and a-adducin alleles,ific oligonucleotide hybridization was as follows: the
respectively; gACE,i and gG460,i are genotype parameterswild-type probe (for Gly460) was 59 TTCTGCCCTTC
assigned on the basis of genetic models. Thus, for addi-CTC 39, and the mutated probe (for Trp460) was 59
TTCTGCCATTCCTC 39. They were labeled with bacte- tive allelic effects models, individuals were assigned a
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Table 1. Baseline clinical characteristics of the 145 patients who underwent a sodium (Na)-sensitivity test
a-Adducin polymorphism ACE polymorphism
Gly460Gly Gly460Trp Trp460Trp I/I I/D D/D
Variable All samples (N 5 103) (N 5 38) (N 5 4) (N 5 21) (N 5 73) (N 5 51)
Sex 127 M/18 F 92 M/11 F 31 M/7 F 4 M/0 F 19 M/2 F 64 M/9 F 44 M/7 F
BMI 25.660.23 25.360.26 26.260.53 27.561.54 24.760.56 26.160.36 25.260.33
Age years 43.660.73 42.860.91 45.761.20 46.264.5 43.862.23 43.860.97 42.461.28
Years of hypertension 4.961.15 3.760.53 4.260.96 2.761.20 3.560.99 4.660.74 2.860.60
GFR mL/min (adj. to 1.73 m2 BSA) 113.661.9 112.962.22 114.963.89 118.468.45 112.264.29 112.762.62 115.463.43
Na serum mEq/L 141.060.2 141.160.2 140.960.3 141.260.8 140.760.5 140.960.3 141.360.3
K serum mEq/L 4.1960.02 4.1860.03 4.1960.05 4.3260.018 4.160.06 4.260.04 4.260.04
Ur Na excretion mEq/24 h 149.964.39 154.465.63 135.965.69 169.0633.6 146.562.91 154.266.2 145.167.31
Ur K excretion mEq/24 h 54.961.41 54.161.62 56.262.96 61.768.95 56.163.95 56.062.03 52.762.22
Ur creatinine excretion g/24 h
(adj. to 1.73 m2 BSA) 1.1260.02 1.1060.02 1.1560.04 1.2360.13 1.1260.05 1.1360.03 1.1060.04
Systolic BP mm Hg 148.061.18 147.861.28 149.162.71 140.669.00 149.862.91 145.661.63 151.961.99
Diastolic BP mm Hg 99.560.72 99.460.81 99.961.60 97.264.60 98.661.84 99.0461.05 100.561.18
Mean BP mm Hg 115.660.82 115.560.90 116.361.91 111.765.70 114.762.09 114.561.18 117.661.35
PRA ng/mL · h 0.9960.06 1.0860.08 0.8260.08 0.4960.19 1.2460.19 1.0560.09 0.8260.08
Abbreviations are: BMI, body mass index; GFR, glomerular filtration rate; Ur, urinary; BP, blood pressure; PRA, plasma renin activity.
value of 0 if they were homozygous for one allele, 1/2
if heterozygous, and 1 if homozygous for the opposite
allele. For dominant models, individuals were assigned
a value of 0 if homozygous for one allele and 1 if hetero-
zygous or homozygous for the opposite allele. bInt is a
coefficient measuring the effect of interaction between
the two loci; gInt.i is a genotype interaction term created
by simply multiplying relevant gACE.i and gG460.i terms used
in the model; and ei is an error term. By fitting models
with and without bInt fixed to 0, hypothesis tests concern-
ing the interaction effect could be pursued.
RESULTS
The polymorphisms were in the Hardy–Weinberg equi-
librium for both the a-adducin (test for deviation, P 5
0.97) and ACE (P 5 0.82) loci. This should have ensured
us that the results obtained were not due to sampling or
stratification errors. Baseline clinical characteristics are
summarized in Table 1 for the total sample and for sub- Fig. 1. Baseline supine plasma renin activity as a function of angioten-
sin converting enzyme (ACE) and the a-adducin genotype.groups divided according to a-adducin and ACE geno-
types. All variables considered were similar among the
different subgroups, except PRA, which decreased as a
function of the number of copies of the 460Trp or D
mmol/day. However, the 95% CI was relatively smallalleles (Fig. 1). The phenomenon is further analyzed in
(141.2 to 158.6 mmol/day).Table 2, in which the trend for PRA decrease appears
to be additive between the 460Trp and D alleles. Unfor- Analysis of genotype–phenotype associations for
tunately, this sample did not contain any Trp460Trp D/D
a-adducin and ACE independently
individual, so that only eight of all nine possible geno-
Blood pressure change according to the ACE geno-types were found because of the rare frequency of the
type. The ACE genotype was not associated with anyTrp460Trp genotype. Although our patients received
BP change after loading (I/I 3.5 6 1.3; I/D 3.9 6 0.7; D/Drecommendations to maintain their Na intake at approxi-
3.8 6 0.9 mm Hg, P 5 NS).mately 150 mmol/day, not all of them did so. In fact, the
Blood pressure change according to the a-adducin ge-range of urinary Na excretion, although similar within
notype. Only four Trp460Trp homozygous hyperten-the different genotypes, was relatively wide, with the
extreme values of daily intake ranging from 65 to 131 sives were found in the present sample. For this reason,
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Table 2. Analysis of variance (ANOVA) with basal plasma renin activity (PRA) as the dependent variable and the genotype for angiotensin
converting enzyme (ACE) and a-adducin as the independent variables
Source of variation F Significance of F % Variance explained Actual %
Main effects 3.675 0.007 Total variance 9.7
ACE genotype 4.232 0.017 Variance explained by ACE 4.4
a-Adducin genotype 4.104 0.019 Variance explained by a-adducin 5.3
Two-way interactions 0.392 0.759
The model is highly significant, and the ACE and a-adducin genotypes contribute in a quantitatively similar way (around 5% each) to explain the total variance
of PRA. The insignificant two-way interaction indicates that the rate of decline of PRA as a function of the number of D alleles is roughly parallel for each a-adducin
genotype and vice-versa. In other words, the dose of D and 460Trp alleles contribute independently to decrease PRA.
tients with the 460Trp allele of a-adducin had increases
in their BP values that likely occurred in order to excrete
the same quantity of Na (0.07 6 0.02 mm Hg/mmol
Na for Gly460Gly and 0.19 6 0.016 for Gly460Trp 1
Trp460Trp, P , 0.001).
Genotype–phenotype associations: Analysis for
a-adducin and ACE combined
When the effects of the two polymorphisms were ana-
lyzed together, ACE and a-adducin displayed a signifi-
cant synergistic effect on the BP increase after loading
and on the pressure-natriuresis relationship, since a large
pressor effect of the ACE D allele could be seen only
in the presence of the 469Trp allele (Fig. 3). Such an
epistatic interaction was tested under different genetic
assumptions. Analyses that assumed that the a-adducin
460Trp and ACE D alleles were codominant produced
the best fit to the data. Table 3 reports the results of the
model fitting, concentrating on the interaction terms for
the additive contribution of either a-adducin and ACE
Fig. 2. Frequency distribution of mean blood pressure change with to the model. Clearly, the model that included an interac-
intravenous acute Na load according to the a-adducin genotype. tion effect fitted the data substantially better than the
model assuming that the loci have independent effects.
In fact, the ACE locus effect is brought to light only in
the context of its interaction with the 460Trp alleles, ain the present analysis their BP changes with loading and
phenomenon recently reviewed by Frankel and Schorkdepletion were counted with Gly460Trp heterozygotes.
[31]. Note that the inclusion of the interaction term intoThe average BP increase after loading was smaller in
the model doubled the variance explained (from 7.7 topatients homozygous for the Gly460 allele than in those
bearing at least one 460Trp allele (2.5 6 0.6 vs. 7.0 6 15.5%). Similar results were found for
DMBP
NaUr
. Also, in
0.9 mm Hg, P 5 0.0001), although there was a substantial
overlap of the BP changes (Fig. 2). this case, the assumption of interactive allelic effects at
Pressure natriuresis. Because of our experimental pro- each locus fits the data better, and the variance explained
tocol, pressure natriuresis could only be evaluated by by the model that took into account the epistatic interac-
computing the ratio between the BP increase during tion again doubled (from 5.4 to 12.1%; Table 4).
loading as a function of the absolute amount of Na ex-
creted during loading 1DMBPNaUr 2; however, taking into ac- DISCUSSION
The present results show that: (1) Patients possessingcount its linearity [30], our estimate should be a reason-
at least one copy of the 460Trp allele of a-adducin andable approximation. The results are in substantial
the D/D genotype are the most responsive to an acuteagreement with those of the absolute BP change after
Na load. (2) ACE and a-adducin interact epistaticallyloading. No difference was seen among the ACE geno-
in the BP, increasing with the Na load; and (3) the num-types (I/I 0.07 6 0.03 mmol Na/mm Hg; I/D 0.12 6 0.02;
D/D 0.09 6 0.02, P 5 NS), while the hypertensive pa- ber of copies of 460Trp and of the D allele independently
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Table 3. Regression model fitting results assuming independent
effects and also taking into account the interaction effects between
the loci for blood pressure increase after Na load
Independent effects Interaction effects
F F
ACE/adducin statistics R2 P statistics R2 P
Add/Add 5.95 7.73% 0.0033 8.16 15.49% 0.0001
Add/Dom 0.02 0.03% 0.9777 1.04 2.16% 0.3770
Add/Rec 7.73 9.82% 0.0006 8.13 14.76% 0.0001
Dom/Add 5.85 7.62% 0.0036 6.56 12.25% 0.0003
Dom/Dom 0.01 0.00% 0.9909 0.01 0.00% 0.9909
Dom/Rec 7.68 9.76% 0.0007 6.97 12.91% 0.0002
Rec/Add 5.99 7.79% 0.0032 7.26 13.38% 0.0001
Rec/Dom 0.06 0.08% 0.9450 1.04 2.17% 0.3755
Rec/Rec 7.77 9.86% 0.0006 7.13 13.17% 0.0002
Add, Dom, and Rec are the assumption of additivity, dominance, or recessivity,
respectively, of the ACE/a-adducin alleles. The first entry gives the F-statistic, the
second the variability explained by the model (R2) and the third the P value
associated with the F-statistic for the fit of the regression model.
Table 4. Regression model fitting results assuming independent
effects and also taking into account the interaction effects
between the loci for
DMBP
NaUr
Independent effects Interaction effects
F F
ACE/adducin statistics R2 P statistics R2 P
Add/Add 3.96 5.36% 0.0211 6.37 12.08% 0.0004
Add/Dom 0.14 0.2% 0.8658 0.39 0.84% 0.7588
Add/Rec 6.04 7.95% 0.0030 6.47 12.25% 0.0004
Dom/Add 4.04 5.45% 0.0198 5.57 10.74% 0.0012
Dom/Dom 0.39 0.55% 0.6805 0.39 0.55% 0.6805
Dom/Rec 6.17 8.10% 0.0027 6.05 11.55% 0.0007
Rec/Add 4.45 5.97% 0.0134 4.72 9.25% 0.0036
Rec/Dom 0.37 0.52% 0.6924 0.44 0.95% 0.7226
Rec/Rec 6.43 8.41% 0.0021 5.35 10.36% 0.0016
Add, Dom, and Rec are the assumption of additivity, dominance, or recessivity,
respectively, of the ACE/a-adducin alleles. The first entry gives the F-statistic, the
second the variability explained by the model (R2) and the third the P value
associated with the F-statistic for the fit of the regression model.
a larger renal Na retention for any given level of Na
intake. Note that this also would have made them more
Fig. 3. (A) Change of mean blood pressure with intravenous acute responsive to the infused Na load.
Na load as a function of ACE and a-adducin genotype. (B) Pressure Renal tubular cells transfected with the “hyperten-
natriuresis 1DMBPNaUr 2 with intravenous acute Na load as a function of sive” rat a-adducin variant have faster activity of their
ACE and the a-adducin genotype. Na1,K1 pump [16]. Humans and rats have different poly-
morphisms in the a-adducin subunit, but both interact
with Na1,K1 pump, the “hypertensive” variants of both
species have greater affinity for the Na1,K1 pump thancause a decrease of PRA. Low PRA, which is commonly
the “normotensive” variants [33]. Taken together, all offound in salt-sensitive individuals [1], is usually consid-
these findings suggest that adducin could affect renalered secondary to relative expansion of extracellular
tubular reabsorption through the modulation of Na1,K1-fluid volume. It is believed that salt-sensitive individuals
pump activity.have a relatively blunted RAS [32]. Changes in Na intake
The D allele of ACE gene is associated with a highermay affect the RAS, but this was not seen in our patients,
ACE concentration in several tissues as normal heartbecause all of our patients had been on similar Na intake
[25], lymphocytes [26], and proximal tubular cells [27].for at least one month before the study. The most likely
explanation is that the D and the 460Trp alleles cause Although direct evidence that its enzymatic activity
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should produce locally acting Ang II is available only 460Trp allele. It is interesting to note that in all cases,
for vascular ACE [34], other circumstantial evidence
the BP change with load and the
DMBP
NaUr
relationship
suggests that ACE plays an important role in the regula-
tion of BP, particularly in the experimental setup of gene appeared to be linearly incremental by adding increasing
targeting in mice, animals that express only serum ACE doses of D alleles (from 0 to 2) in the different a-adducin
but lack tissue ACE and have a low BP [35]. Increased genotypes, as summarized in Figure 3.
pressor responsiveness to exogenous Ang I and a higher In spite of being a plausible candidate, the majority
generation of Ang II have been described in young nor- of the studies have not found an association between
motensive humans with the D/D ACE genotype [36], the ACE I/D polymorphism and hypertension until very
which is consistent with the hypothesis that the D allele recently, when large samples have been used [42–44];
however, these studies found only a relatively small sig-is associated with larger intrarenal generation of Ang II,
nificance level. The reason for the difficulty in findinga phenomenon that should promote renal Na retention.
positive results may be that in order to be clearly detect-Others, who failed to confirm this finding [37], performed
able, the effect of ACE genotype must be studied in aAng I infusion under inhibition of renin, and it is not
proper experimental setting that takes into account theknown how this maneuver affects the tissue ACE level
appropriate combination of interacting alleles of otherin view of the contrasting effects of the salt diet on tissue
disease susceptibility gene(s). While recognizing thatand circulating RAS [38].
such an interaction without any a priori knowledge ofThe question of why there is an additive effect between
the potential pathophysiological role of the interactingACE and a-adducin for PRA in basal conditions and
genes could be extremely difficult to prove, it was rela-yet an epistatic interaction exists for the BP response to
tively easy in the present study, where an appropriate
volume infusion and to
DMBP
NaUr
is an important one. In hypotheses and experimental setup had been used, and
in which controls for environmental noise were devised.our study, each individual’s PRA value may reflect a
As mentioned at the beginning of this article, the inter-long-term intrinsic renal ability to regulate body Na and
action between two candidate genes contributing to BPvolumes. Differences in the time course of the resetting
regulation and mapping on separate chromosomes pro-of the homeostatic regulation of BP/body Na relation-
vides very strong evidence for their causal involvement.ship and in the nature of the environmental stimuli may
Whether the long-term effect on BP levels caused byaccount for the epistatic interaction observed with the
the ACE and a-adducin polymorphisms is synergistic,Na infusion [39]. In fact, increased perfusion pressure
additive or negligible in unselected, and non-Na loadedgenerated by Na loading may depress tubular Na reab-
hypertensive patients remains to be determined.sorption by removing Na transport units from the lumi-
nal membranes, as well as Na1,K1 pump units from the
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